The roles of c-rel and interleukin-2 in tolerance: A molecular explanation of self-nonself discrimination

Immunology and Cell Biology

Volumn 89, Issue 1, 2011, Pages 27-32

  Liou, Hsiou Chi ^a   Smith, Kendall A ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

autoimmunity; c Rel; IL 2; immune tolerance; NF kB

Indexed keywords

INTERLEUKIN 2; TRANSCRIPTION FACTOR REL;

APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL MATURATION; CYTOKINE PRODUCTION; GENE DELETION; HEMATOPOIESIS; HUMAN; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRE B LYMPHOCYTE; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; AUTOIMMUNE DISEASES; CLONAL ANERGY; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; PROTO-ONCOGENE PROTEINS C-REL;

MUS; MUS MUSCULUS;

EID: 78651083664     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.120     Document Type: Review

References (82)

1. Burnet FM. A modification of Jernes theory of antibody production using the concept of clonal selection. Aust J Sci 1957; 20: 67-77.
2. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172: 603-606.
3. Goodnow CC, Crosbie J, Jorgensen H, Brink RA, Basten A. Induction of self-tolerance in mature peripheral B lymphocytes. Nature 1989; 342: 385-391.
4. Goodnow C C, Crosbie J, Adelstein S, Lavoie TB, Smith-Gill SJ, Brink RA et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988; 334: 676-682.
5. Cantrell DA, Smith KA. The interleukin-2 T-cell system: a new cell growth model. Science 1984; 224: 1312-1316.
6. + T cells. J Exp Med 1997; 186: 757-766.
7. Chiodetti L, Barber D, Schwartz R. Biallelic expression of the IL-2 locus under optimal stimulation conditions. Eur J Immunol 2000; 30: 2157-2163.
8. Viola A, Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds. Science 1996; 273: 104-106.
9. Labrecque N, Whitfield LS, Obst R, Waltzinger C, Benoist C, Mathis D. How Much TCR does a T cell need? Immunity 2001; 15: 71-82.
10. Smith KA. The Quantal Theory of Immunity. World Scientific Publishing Co Pte. Ltd., Singapore, 2010.
11. Smith K, Popmihajlov Z. The quantal theory of immunity and the interleukin-2- dependent negative feedback regulation of the immuune response. Immunol Rev 2008; 224: 124-140.
12. Smith K. The quantal theory of immunity. Cell research 2006; 16: 11-19.
13. Smith K. The quantal theory of how the immune system discriminates between self and non-self. Med Immunol 2004; 3: 3.
14. Healy JI, Dolmetsch RE, Timmerman LA, Cyster JG, Thomas ML, Crabtree GR et al. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 1997; 6: 419-428.
15. Nossal GJ, Pike BL. Evidence for the clonal abortion theory of B-lymphocyte tolerance. J Exp Med 1975; 141: 904-917.
16. Raff MC, OwenJJ, Cooper MD, Lawton III AR, Megson M, Gathings WE. Differences in susceptibility of mature and immature mouse B lymphocytes to anti-immunoglobulininduced immunoglobulin suppression in vitro. Possible implications for B-cell tolerance to self. J Exp Med 1975; 142: 1052-1064.
17. Sidman CL, Unanue ER. Receptor-mediated inactivation of early B lymphocytes. Nature 1975; 257: 149-151.
18. Norvell A, Mandik L, Monroe JG. Engagement of the antigen-receptor on immature murine B lymphocytes results in death by apoptosis. J Immunol 1995; 154: 4404-4413.
19. Carman JA, Wechsler-Reya RJ, Monroe JG. Immature stage B cells enter but do not progress beyond the early G1 phase of the cell cycle in response to antigen receptor signaling. J Immunol 1996; 156: 4562-4569.
20. Monroe JG. Tolerance sensitivity of immature-stage B cells: can developmentally regulated B cell antigen receptor (BCR) signal transduction play a role? J Immunol 1996; 156: 2657-2660.
21. Gerondakis S, Strasser A, Metcalf D, Grigoriadis G, Scheerlinck JY, Grumont RJ. Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocytemacrophage colony-stimulating factor. Proc Natl Acad Sci USA 1996; 93: 3405-3409.
22. Grumont R, Rourke I, OReilly L, Strasser A, MiyakeK, Sha W et al. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogenactivated cells. J Exp Med 1998; 187: p663-p674.
23. Liou H, Jin Z, Tumang J, Andjelic S, Smith K, Liou M. c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function. Int Immunol 1999; 11: p361-p371.
24. Liou H, Hsia C. Distinction between c-Rel and other NF-kappaB proteins in immunity and disease. Bioessays 2003; 8: 767-780.
25. Kontgen F, Grumont RJ, Strasser A, Metcalf D, Li R, Tarlinton D et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev 1995; 9: 1965-1977.
26. Owyang A, Tumang J, Schram B, Hsia C, Behrens T, Rothstein T et al. c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis. J Immunol 2001; 167: p4948-p4956.
27. Grumont RJ, Rourke IJ, OReilly LA, Strasser A, Miyake K, Sha W et al. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogenactivated cells. J Exp Med 1998; 187: 663-674.
28. Grumont RJ, Rourke IJ, Gerondakis S. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev 1999; 13: 400-411.
29. Hsia C, Cheng S, Owyang A, Dowdy S, Liou H. c-Rel regulation of the cell cycle in primary mouse B lymphocytes [In Process Citation]. Int Immunol 2002; 14: p905-p916.
30. Cheng S, Hsia C, Leone G, Liou H. Cyclin E and Bcl-xl cooperatively induce cell cycle progression in c-Rel(-/-) B cells. Oncogene 2003; 22: 8472-8486.
31. Feng B, Cheng S, Hsia C, King L, Monroe J, Liou H. NF-kB inducible Bcl-X and cyclin E promote immature B cell survival and proliferation. Cell Immunol 2005; 232: 9-20.
32. Sproul TW, Malapati S, Kim J, Pierce SK. Cutting edge: B cell antigen receptor signaling occurs outside lipid rafts in immature B cells. J Immunol 2000; 165: 6020-6023.
33. Cheng PC, Cherukuri A, Dykstra M, Malapati S, Sproul T Chen MR, Pierce SK. Floating the raft hypothesis: the roles of lipid rafts in B cell antigen receptor function. Semin Immunol 2001; 13: 107-114.
34. Monroe JG. B-cell antigen receptor signaling in immature-stage B cells: integrating intrinsic and extrinsic signals. Curr Top Microbiol Immunol 2000; 245: 1-29.
35. King LB, Norvell A, Monroe JG. Antigen receptor-induced signal transduction imbalances associated with the negative selection of immature B cells. J Immunol 1999; 162: 2655-2662.
36. Sater RA, Sandel PC, Monroe JG. B cell receptor-induced apoptosis in primary transitional murine B cells: signaling requirements and modulation by T cell help. Int Immunol 1998; 10: 1673-1682.
37. Cheng S, Hsia CY, FengB, Liou ML, Fang X, Pandolfi PP et al. BCR-mediated apoptosis associated with negative selection of immature B cells is selectively dependent on Pten. Cell research 2008; 19: 196-207.
38. Andjelic S, Suzuki H, Kadowaki T, Koyasu S, Liou H. PI-3K is at divergence of the two parallel CD40-mediated pathways for proliferation and apoptsis protection. J Immunol 2000; 165: 3860-3866.
39. Macian F, Garcia-Cozar F, Im SH, Horton HF, Byrne MC, Rao A. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 2002; 109: 719-731.
40. Heissmeyer V, Macian F, Im SH, Varma R, Feske S, Venuprasad K et al. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat Immunol 2004; 5: 255-265.
41. Pipkin M, Sacks J, Cruz-Guilloty F, Lichtenheld M, Bevan M, Rao A. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 2010; 32: 91-103.
42. Naramura M, Jang IK, Kole H, Huang F, Haines D, Gu H. c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation. Nat Immunol 2002; 3: 1192-1199.
43. Bandyopadhya S, Dure M, Paroder M, Soto-Nieves N, Puga I, Macian F. Interleukin 2 gene transcription is regulated by Ikaros-induced changes in histone acetylation in anergic T cells. Blood 2007; 109: 2878-2886.
44. Martino A, Holmes IV JH, Lord JD, Moon JJ, Nelson BH. Stat5 and Sp1 regulate transcription of the cyclin D2 gene in response to IL-2. J Immunol 2001; 166: 1723-1729.
45. Nourse J, Firpo E, Flanagan W, Coats S, Polyak K, Lee M et al. Interleukin2-mediated elimination of the p27Kip1 cyclin-dependent inhibitor prevented by rapamycin. Nature 1994; 372: 570-573.
46. Zhang J, Scordi I, Smyth MJ, Lichtenheld MG. Interleukin 2 receptor signaling regulates the perforin gene through signal transducer and activator of transcription (Stat)5 activation of two enhancers. J Exp Med 1999; 190: 1297-1308.
47. Le Gros G, Ben-Sasson SZ, Seder R, Finkelman FD, Paul WE. Generation of interleukin 4 (IL4)-producing cells in vivo and in vitro: IL2 and IL4 are required for invitro generation of IL4-producing cells. J Exp Med 1990; 172: 921-929.
48. + T cells. Eur J Immunol 1995; 25: 3053-3059.
49. Tumang J, Owyang A, Andjelic S, Jin Z, Hardy R, Liou M et al. c-Rel is essential for B lymphocyte survival and cell cycle progression. Eur J Immunol 1998; 28: p4299-p4312.
50. Thien M, Phan TG, Gardam S, Amesbury M, Basten A, Mackay F et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 2004; 20: 785-798.
51. Do RK, Hatada E, Lee H, Tourigny MR, Hilbert D, Chen-Kiang S. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med 2000; 192: 953-964.
52. Liou H. Sequential induction of NF-kB/Rel family proteins during B cell terminal differentiation. Mol Cell Biol 1994; 14: 5349-5359.
53. Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 1991; 352: 621-624.
54. Kundig TM, Schorle H, Bachmann MF, Hengartner H, Zinkernagel RM, Horak I. Immune responses in interleukin-2-deficient mice. Science 1993; 262: 1059-1061.
55. Cousens LP, Orange JS, Biron CA. Endogenous IL-2 contributes to T cell expansion and IFN-gamma production during lymphocytic choriomeningitis virus infection. J Immunol 1995; 155: 5690-5699.
56. Smith KA. Interleukin-2: inception, impact, and implications. Science 1988; 240: 1169-1176.
57. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene [see comments]. Cell 1993; 75: 253-261.
58. Horak I, Lohler J, Ma A, Smith K. Interleukin-2 deficient mice: A new model to study autoimmunity and self-tolerance. Immunol Rev 1995; 148: 35-44.
59. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-1164.
60. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998; 10: 1969-1980.
61. +CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188: 287-296.
62. Burchill M, Yang J, Vogtenhuber C, Blazar B, Farrar M. IL-2 receptor beta-dependent STAT5 activation is required for the development of FOXP3+ regulatory T cells. J Immunol 2007; 178: 280-290.
63. Brunkow M, Jeffrey E, Hjerrild K, Paeper B, Clark L, Yasayko S-A et al. Disruption of a new forkhead/winked-helix protein, scurfin, results in the fatal lymphoprolierative disorder of the scurfy mouse. Nat Genet 2001; 27: 68-73.
64. Bennet C, Christie J, Ramsdell M, Brunkow M, Ferguson P, Whitesell L et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27: 20-21.
65. Chatlia T, Blaeser F, Ho N, Lederman H, Voularopoulos C, Helms C et al. JM2, encoding a forkhead-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2001; 106: R75-R81.
66. Wildin R, Ramsdell F, Peake J, Faravelli F, Casanova J-L, Buist N et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001; 27: 18-20.
67. + T cells. Nat Immunol 2007; 8: 1353-1362.
68. +CD25+Foxp3+ regulatory T cell survival. Biol Direct 2008; 3: 1745-1757.
69. Feinerman O, Jentsch G, Sneddon M, Emonet T, Smith K, Altan-Bonnet G. Single-cell quantification of IL-2 response by effector and regulatory T cells reveals critical plasticity in immune response. Mol Sys Biol 2010; 6: 437.
70. Min B, McHugh R, Sempowski G, Mackall C, Foucras G, Paul W. Neonates support lymphopenia-induced proliferation. Immunity 2003; 18: 131-140.
71. Klebb G, Autenrieth IB, Haber H, Gillert E, Sadlack B, Smith KA et al. Interleukin-2 Is Indispensable for Development of Immunological Self-Tolerance. Clin Immunol Immunopathol 1996; 81: 282-286.
72. Willerford D, Chen J, Ferry J, Davidson L, Ma A, Alt F. Interleukin-2 receptor alpha chainregulates the size and content of the peripheral lymphoid compartment. Immunity 1995; 3: 521-530.
73. Suzuki H, Kundig TM, Furlonger C, Wakeham A, Timms E, Matsuyama T et al. Deregulated T cell activation autoimmunity in mice lacking interleukin-2 receptor beta. Science 1995; 268: 1472-1476.
74. Gambineri E, Torgerson T, Ochs H. Immune dysregulation polyendocrinopathy enteropathy, X-linked inheritance (IPEX) a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T cell homeostasis. Curr Opin Rheum 2003; 15: 430-435.
75. Caudy A, Reddy S, Chatila T, Atkinson J, Verbsky J. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol 2007; 119: 482-487.
76. Liston A, Siggs O, Goodnow C. Tracing the action of IL-2 in tolerance to islet-specific antigen. Immunol Cell Biol 2007; 85: 338-342.
77. Yamanouchi J, Rainbow D, Serra P, Howlett S, Hunter K, Garner V et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Gen 2007; 39: 329-337.
78. Tang Q, Adams J, Penaranda C, Melli K, Piaggio E, Sgouroudis E et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 2008; 28: 687-697.
79. Grinberg-Bleyer Y, Baeyens A, You S, Elhage R, Fourcade G, Gregoire S et al. IL- 2reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J Exp Med 2010; 207: 1871-1878.
80. Long M, Adler A. Cutting edge: paracrine but not autocrine IL-2 signaling is sustained during early antiviral CD4T cell response. J Immunol 2006; 177: 4247-4261.
81. OGorman W, Dooms H, Thorne S, Kuswanto W, Simonds E, Kruzik P et al. The initial phase of an immune response functions to activate regulatory T cells. J Immunol 2009; 183: 332-339.
82. Kim ST, Takeuchi K, Sun ZY, Touma M, Castro CE, Fahmy A et al. The alphabeta T cell receptor is an anisotropic mechanosensor. J Biol Chem 2009; 284: 31028-31037.